Shenzhen / May 11, 2021 / — The long-awaited second product from Hyper Vision Limited has been announced, and it comes in the form of the Hyprscope. This new technology combines both augmented reality and artificial intelligence. The device overlays AI-based information onto the present image of the sample in real-time, allowing AI to be seamlessly integrated into routine procedures.

The Hyprscope is expected to revolutionize artificial intelligence (AI) to improve cancer diagnosis accuracy and efficiency. A microscope powered by artificial intelligence that can detect tumor cells in histopathology slides will speed up and reduce errors in cancer diagnostic pathology examinations.

In most cancer diagnoses, a biopsy sample will be examined under a microscope to confirm the presence of malignant cells. Even experts who have been identifying cancerous cells for a considerable amount of time can make mistakes. Hyper Vision Limited claims that this AI research aims to reduce the current rate of diagnosis errors, which is roughly 5%.

“Teaching the AI to identify cancer should be similar to teaching it to recognize a tree or a cat visually. You must give the algorithm labeled data and tune it until it recognizes the relevant properties reliably. It can then repeat the process with additional samples. The technique will provide an overlay that identifies potential cancer cells, allowing pathologists to make more accurate diagnoses.” said Yan Jiang, CEO of Hyper Vision Limited.

“By merging artificial intelligence and augmented reality, the goal is to improve diagnosis accuracy and speed, making artificial intelligence more useful to researchers and pathologists who care for patients.” Jiang continued.